StonvexLoading…
StonvexStonvexStonvexCore line items from APOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Q4 2025 2025-11-29 | Q3 2025 2025-08-30 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $1.40B | $1.05B | $704.82M | $346.62M |
Operating Income | $84.47M | $58.70M | $33.82M | $6.93M |
Net Income | $54.13M | $37.51M | $23.65M | $-2.69M |
EPS (Diluted) | $2.52 | $1.74 | $0.97 | $-0.13 |
Total Assets | $1.12B | $1.12B | $1.15B | $1.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $39.52M | $41.31M | $39.53M | $32.83M |
Free Cash Flow OCF − CapEx | $95.16M | $48.31M | $25.45M | $-26.95M |
Shares Outstanding | 21.22M | 21.49M | 21.52M | 21.53M |